Results
24,511 records
Include
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Cheng Chi FungDirector, Chief Technology Officer |  CRDOCredo Technology Group Holding LtdOpen-market sale · 10b5-1 plan | SELL | $725K 4,500 sh |
Congress trades and big insider sales, sent the day they're filed. Free.
Open in TelegramEvery ingested record across SEC Form 4, 13F, House PTRs and Robinhood Chain, searchable by ticker, name or wallet address.
| Score | Actor | Security | Side | Value | Disclosed | Evidence |
|---|---|---|---|---|---|---|
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $725K 4,500 sh |
| Oct 29, 2026 traded Oct 27, 2026 |
| 9 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $384K 2,400 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Wang XiaodongDirector, Chair, Scientific Advisory Brd |  ONCBeOne Medicines Ltd.Open-market sale · 10b5-1 plan | SELL | $603K 1,681 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 |  Kurtz GeorgeDirector, PRESIDENT AND CEO |  CRWDCrowdStrike Holdings, Inc.Open-market sale · 10b5-1 plan | SELL | $44K 163 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $36K 134 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 8 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $845K 2,331 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $45K 170 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 8 | Kurtz GeorgeDirector, PRESIDENT AND CEO | CRWDCrowdStrike Holdings, Inc. Open-market sale · 10b5-1 plan | SELL | $41K 156 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $84K 500 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $94K 600 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Mensinger MikeChief Product Officer |  BBNXBeta Bionics, Inc.Open-market sale · 10b5-1 plan | SELL | $58K 2,650 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Bentley Sheldon RichardFounder |  CSAICLOUDASTRUCTURE, INC.Open-market sale · 10b5-1 plan | SELL | $3,405 1,500 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $131K 800 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 6 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $81K 500 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $460K 1,280 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $313K 880 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Rubinstein JuliePresident and COO |  ADPTAdaptive Biotechnologies CorpOpen-market sale · 10b5-1 plan | SELL | $336K 11.9K sh | Oct 29, 2026 traded Oct 29, 2026 |
| 4 | Boughton SoleilChief Legal Officer |  HIMSHims & Hers Health, Inc.Open-market sale · 10b5-1 plan | SELL | $96K 3,462 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $512K 1,440 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Eisen Anthony MathewDirector |  XYZBlock, Inc.Open-market sale · 10b5-1 plan | SELL | $447K 6,000 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 4 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $443K 1,239 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 4 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $332K 11.7K sh | Oct 29, 2026 traded Oct 28, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $32K 200 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $31K 200 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 3 | Cheng Chi FungDirector, Chief Technology Officer | CRDOCredo Technology Group Holding Ltd Open-market sale · 10b5-1 plan | SELL | $48K 300 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $80K 3,000 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $244K 8,881 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 1 | Wang XiaodongDirector, Chair, Scientific Advisory Brd | ONCBeOne Medicines Ltd. Open-market sale · 10b5-1 plan | SELL | $115K 320 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 0 | Sarowitz Steven IDirector, 10% Owner |  PCTYPaylocity Holding CorpOpen-market sale · 10b5-1 plan | SELL | $17K 100 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 | Rubinstein JuliePresident and COO | ADPTAdaptive Biotechnologies Corp Open-market sale · 10b5-1 plan | SELL | $5,780 200 sh | Oct 29, 2026 traded Oct 28, 2026 |
| 0 |  Robinhood Markets, Inc.10% Owner |  RVIRobinhood Ventures Fund IOpen-market sale · 10b5-1 plan | SELL | $4,725 189 sh | Oct 29, 2026 traded Oct 27, 2026 |
| 56 | Polito KarynDirector |  BBTBeacon Financial CorpOpen-market purchase | BUY | $31K 1,000 sh | Oct 28, 2026 traded Oct 26, 2026 |
| 53 | Portman David J.10% Owner |  LONALeonaBio, Inc.Open-market purchase | BUY | $9.92B 3.15M sh | Oct 28, 2026 traded Oct 26, 2026 |
| 53 | Portman David J.10% Owner | LONALeonaBio, Inc. Open-market purchase | BUY | $17.33B 5.50M sh | Oct 28, 2026 traded Oct 26, 2026 |
| 50 | Babcock KenDirector |  LBRTLiberty Energy Inc.Open-market purchase | BUY | $223K 14.5K sh | Oct 28, 2026 traded Oct 26, 2026 |
| 48 | Rosengren Eric SDirector | BBTBeacon Financial Corp Open-market purchase | BUY | $21K 700 sh | Oct 28, 2026 traded Oct 28, 2026 |
| 47 | Gouws HenryHead of Prod., Dir. of Ergo |  DRDDRDGOLD LTDOpen-market sale | SELL | $218K 89.2K sh | Oct 28, 2026 traded Oct 27, 2026 |
| 47 | Kruger KevinHead of Technical Services | DRDDRDGOLD LTD Open-market sale | SELL | $180K 73.8K sh | Oct 28, 2026 traded Oct 27, 2026 |
| 47 | Moloto KgaboGeneral Manager FWGR Ops. | DRDDRDGOLD LTD Open-market sale | SELL | $54K 22.0K sh | Oct 28, 2026 traded Oct 27, 2026 |
| 47 | Lindecke DeanGeneral Manager Ergo Ops. | DRDDRDGOLD LTD Open-market sale | SELL | $119K 48.9K sh | Oct 28, 2026 traded Oct 27, 2026 |